JPMorgan Chase & Co’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-618,089
| Closed | -$28.7M | – | 6753 |
|
|
2023
Q2 | $28.7M | Buy |
618,089
+571,732
| +1,233% | +$26.6M | ﹤0.01% | 1317 |
|
|
2023
Q1 | $1.33M | Buy |
46,357
+8,775
| +23% | +$251K | ﹤0.01% | 3275 |
|
|
2022
Q4 | $1.17M | Buy |
37,582
+12,728
| +51% | +$397K | ﹤0.01% | 3269 |
|
|
2022
Q3 | $504K | Buy |
24,854
+4,864
| +24% | +$98.6K | ﹤0.01% | 3743 |
|
|
2022
Q2 | $311K | Buy |
19,990
+9,901
| +98% | +$154K | ﹤0.01% | 4119 |
|
|
2022
Q1 | $193K | Buy |
10,089
+1,567
| +18% | +$30K | ﹤0.01% | 4466 |
|
|
2021
Q4 | $215K | Buy |
+8,522
| New | +$215K | ﹤0.01% | 4497 |
|